DEUTSCHE BANK AG\ - CHECKMATE PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 38 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$803,000
-52.0%
134,760
-2.3%
0.00%
-100.0%
Q1 2021$1,674,000
-43.6%
137,959
-32.2%
0.00%
-50.0%
Q4 2020$2,970,000
+2.2%
203,534
-19.4%
0.00%0.0%
Q3 2020$2,907,000–252,531–0.00%–
 Download
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders